Literature DB >> 24934093

Medical models of teleoncology: current status and future directions.

Sabe Sabesan1.   

Abstract

Teleoncology has been adopted by many centers to provide cancer care closer to home for rural, remote, Indigenous and other disadvantaged people of our communities. A variety of medical models of teleoncology exist to provide various medical oncology services. While most centers use teleoncology to complement their face-to-face outreach services, some centers have replaced face-to-face with teleoncology models. Selection of patients and scheduling of clinics would depend on various factors including experience of the clinicians, complexity of treatment provided, capabilities and workforce of rural sites, and patient preferences. Many small studies reported high satisfaction rates of these models among patients and health professionals including Indigenous populations. One single center study reports that it is safe to supervise chemotherapy delivery remotely and many studies report cost savings to the health systems. Further studies on safety aspects of teleoncology are needed to further improve the current models. Future teleoncology models would need to include Web-based models, mobile technologies and remote chemotherapy supervision models so that patients from most rural towns could have at least some of their cancer care closer to home.
© 2014 Wiley Publishing Asia Pty Ltd.

Entities:  

Keywords:  cancer; model of care; rural; telehealth; telemedicine

Mesh:

Year:  2014        PMID: 24934093     DOI: 10.1111/ajco.12225

Source DB:  PubMed          Journal:  Asia Pac J Clin Oncol        ISSN: 1743-7555            Impact factor:   2.601


  10 in total

Review 1.  The Role of Telemedicine in Providing Thoracic Oncology Care to Remote Areas of British Columbia.

Authors:  Michael F Humer; Barbara G Campling
Journal:  Curr Oncol Rep       Date:  2017-08       Impact factor: 5.075

2.  Patient preferences on the use of technology in cancer surveillance after curative surgery: A cross-sectional analysis.

Authors:  Amblessed E Onuma; Elizabeth Palmer Kelly; Jeffery Chakedis; Anghela Z Paredes; Diamantis I Tsilimigras; Brianne Wiemann; Morgan Johnson; Katiuscha Merath; Ozgur Akgul; Jordan Cloyd; Timothy M Pawlik
Journal:  Surgery       Date:  2019-02-13       Impact factor: 3.982

3.  Factors Influencing Telemedicine Use at a Northern New England Cancer Center During the COVID-19 Pandemic.

Authors:  Matthew B Mackwood; Tor D Tosteson; Jennifer A Alford-Teaster; Kevin M Curtis; Mary L Lowry; Jennifer A Snide; Wenyan Zhao; Anna N A Tosteson
Journal:  JCO Oncol Pract       Date:  2022-04-21

4.  Virtual visits among gynecologic oncology patients during the COVID-19 pandemic are accessible across the social vulnerability spectrum.

Authors:  Lindsey A McAlarnen; Shirng-Wern Tsaih; Rana Aliani; Natasha M Simske; Elizabeth E Hopp
Journal:  Gynecol Oncol       Date:  2021-05-11       Impact factor: 5.304

5.  Communicating Effectively via Tele-oncology (Comskil TeleOnc): a Guide for Best Practices for Communication Skills in Virtual Cancer Care.

Authors:  Smita C Banerjee; Jessica M Staley; Frances Howell; Charlotte Malling; Aimee Moreno; Chris Kotsen; Dhwani Parikh; Patricia A Parker
Journal:  J Cancer Educ       Date:  2021-02-05       Impact factor: 1.771

Review 6.  Use of Telemedicine in Care of Hematologic Malignancy Patients: Challenges and Opportunities.

Authors:  Jennifer Lloyd; Catherine J Lee
Journal:  Curr Hematol Malig Rep       Date:  2022-01-11       Impact factor: 4.213

Review 7.  Benefits and drawbacks of videoconferencing for collaborating multidisciplinary teams in regional oncology networks: a scoping review.

Authors:  Lidia S van Huizen; Pieter U Dijkstra; Sjoukje van der Werf; Kees Ahaus; Jan Ln Roodenburg
Journal:  BMJ Open       Date:  2021-12-09       Impact factor: 2.692

8.  Adoption of Telemedicine in a Rural US Cancer Center Amid the COVID-19 Pandemic: Qualitative Study.

Authors:  Matthew Mackwood; Rebecca Butcher; Danielle Vaclavik; Jennifer A Alford-Teaster; Kevin M Curtis; Mary Lowry; Tor D Tosteson; Wenyan Zhao; Anna N A Tosteson
Journal:  JMIR Cancer       Date:  2022-08-16

Review 9.  Patient perspectives of telemedicine in gynecologic oncology during COVID.

Authors:  Christina Nestlerode; James Pavelka; Jack Basil; Kevin Schuler; Angela N Fellner; Mostafa Ghaderian; Robert Neff
Journal:  Gynecol Oncol Rep       Date:  2022-09-28

10.  Strategies to Maximize Available Resources With Minimum Cost Escalation for Improving Radiation Therapy Accessibility in the Post-Coronavirus Disease 2019 Era: An Analysis for Asia.

Authors:  Niloy R Datta; Sneha Datta; Massoud Samiei
Journal:  Adv Radiat Oncol       Date:  2020-09-24
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.